Concurrent Management of a Patient with Toxic Epidermal Necrolysis and Coronavirus Disease-19: A Case Presentation
Toxic epidermal necrolysis (TEN) is a serious cutaneous adverse reaction with high mortality rate. The severe acute respiratory syndrome-coronavirus-2 virus disease represented a global pandemic known as coronavirus disease-2019 (COVID-19), without exact cure up to date. The usage of immunosuppressi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-09-01
|
Series: | Türk Yoğun Bakim Derneği Dergisi |
Subjects: | |
Online Access: |
http://www.turkishjic.org/archives/archive-detail/article-preview/concurrent-management-of-a-patient-with-toxic-epid/47545
|
Summary: | Toxic epidermal necrolysis (TEN) is a serious cutaneous adverse reaction with high mortality rate. The severe acute respiratory syndrome-coronavirus-2 virus disease represented a global pandemic known as coronavirus disease-2019 (COVID-19), without exact cure up to date. The usage of immunosuppressive drugs during COVID-19 infection is a major clinical challenge; however, it seems inevitable in rare cases. Here we aimed to report a patient, who was treated concomitantly for TEN and COVID-19 with a good clinical outcome by reviewing the existing literature. |
---|---|
ISSN: | 2146-6416 2147-267X |